Hyperleukocytosis in Leukemia—An Emergency

  • Janice P. Dutcher

Abstract

Hyperleukocytosis is defined as a white blood cell count (WBC) of greater than 100,000/µl and is usually a feature of myeloproliferative or lymphoproliferative disorders (leukemias). An elevated WBC may occur in the chronic leukemias, in which there is a proliferation of the mature forms of white blood cells, or in acute leukemias, including blastic crisis of chronic myelocytic leukemias, in which the hyperleukocytosis reflects primarily blasts.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lichtman MA, Rowe JM: Hyperleukocytic leukemia: Rheologic clinical and therapeutic considerations. Blood 650: 279–283, 1982.Google Scholar
  2. 2.
    Lichtman MA: Rheology of leukocytes, leukocyte suspensions and blood in leukemia: Possible relationship to clinical manifestations. J Clin Invest 52: 350–358, 1973.PubMedCrossRefGoogle Scholar
  3. 3.
    Lichtman MA: Cellular deformability during maturation of the myeloblast. N Engl J Med 283: 943–948, 1970.PubMedCrossRefGoogle Scholar
  4. 4.
    Lichtman MA, Kearney EA: The filterability of normal and leukemic leukocytes. Blood Cells 2: 491–495, 1976.Google Scholar
  5. 5.
    Dintenfass L: Viscosity of the packed red and white blood cells. Exp Mol Pathol 41: 597–601, 1965.CrossRefGoogle Scholar
  6. 6.
    Palmer AA: A study of blood flow in minute vessels of the pancreatic region of the rat with reference to intermittent corpuscular flow in individual capillaries. J Exp Physiol 44: 149–156, 1959.Google Scholar
  7. 7.
    Steinberg MH, Charm SE: Effect of high concentrations of leukocytes on whole blood viscosity. Blood 38: 299–301, 1971.PubMedGoogle Scholar
  8. 8.
    Green RA, Nichols NJ, King EJ: Alveolar-capillary block due to leukemic infiltration of the lung. Am Rev Respir Dis 80: 895–900, 1959.Google Scholar
  9. 9.
    Hild DH, Myers TJ: Hyperviscosity in chronic granulocytic leukemia. Cancer 46: 1418–1421, 1980.PubMedCrossRefGoogle Scholar
  10. 10.
    Stirling ML, Parker AC, Keller AJ, Urbaniak SJ: Leukapheresis for papilloedema in chronic granulocytic leukaemia. Br Med J 9: 676–677, 1977.CrossRefGoogle Scholar
  11. 11.
    McKee LC, Collins RD: Intravascular leukocyte thrombi and aggregates as a cause of morbidity and mortality in leukemia. Medicine (Baltimore) 53: 463–479, 1974.CrossRefGoogle Scholar
  12. 12.
    Bloom R, DaSilva AMT, Bracey A: Reversible respiratory failure due to intravascular leukostasis in chronic myelogenous leukemia. Am J Med 67: 679–683, 1979.PubMedCrossRefGoogle Scholar
  13. 13.
    Vernant JP, Brun B, Mannoni P, Dreyfus B: Respiratory distress of hyperleukocytic granulocytic leukemias. Cancer 44: 264–268, 1979.PubMedCrossRefGoogle Scholar
  14. 14.
    Prakash UBS, Divertie MB, Banks PM: Aggressive therapy in acute respiratory failure from leukemic pulmonary infiltrates. Chest 75: 345–350, 1970.CrossRefGoogle Scholar
  15. 15.
    Resnick ME, Berkowitz RD, Rodman T: Diffuse interstitial leukemic infiltration of the lungs producing the alveolar-capillary block syndrome. Am J Med 31: 149–153, 1961.PubMedCrossRefGoogle Scholar
  16. 16.
    Lokich JJ, Moloney WC: Fatal pulmonary leukostasis following treatment in acute myelogenous leukemia. Arch Intern Med 130: 759–762, 1972.PubMedCrossRefGoogle Scholar
  17. 17.
    Old JW, Smith WW, Grampa G: Human lung in leukemia: Observations on alveolar capillary leukostasis with reference to pathologic physiology. Am J Pathol 31: 605, 1955 (abstract).Google Scholar
  18. 18.
    Bodey GP, Powell RD, Hersh EM, Yeterian A, Freireich EJ: Pulmonary complications of acute leukemia. Cancer 19: 781–793, 1966.PubMedCrossRefGoogle Scholar
  19. 19.
    Cuttner J, Holland JF, Norton L, Ambinder E, Button G, Meyer RJ: Therapeutic leukapheresis for hyperleukocytosis in acute myelocytic leukemia. Med Pediatr Oncol 11: 76–78, 1983.PubMedCrossRefGoogle Scholar
  20. 20.
    Lester TJ, Johnson JW, Cuttner J: Pulmonary leukostasis as the single worst prognostic factor in patients with acute myelocytic leukemia and hyperleukocytosis. Am J Med 79: 43–48, 1985.PubMedCrossRefGoogle Scholar
  21. 21.
    Hewlett RI, Wilson AF: Adult respiratory distress syndrome (ARDS) following aggressive management of extensive acute lymphoblastic leukemia. Cancer 39: 2422–2425, 1977.PubMedCrossRefGoogle Scholar
  22. 22.
    Dutcher JP, Wiernik PH: Unpublished observations.Google Scholar
  23. 23.
    Fritz RD, Forkner CE, Freireich EJ, Frei E, Thomas LB: The association of fatal intracranial hemorrhage and “blastic crisis” in patients with acute leukemia. N Engl J Med 261: 59–64, 1959.PubMedCrossRefGoogle Scholar
  24. 24.
    Phair JP, Anderson RE, Namiki H: The central nervous system in leukemia. Ann Intern Med 61: 863–875, 1964.PubMedCrossRefGoogle Scholar
  25. 25.
    Wiernik PH, Serpick AA: Factors affecting remission and survival in adult acute nonlymphocytic leukemia (ANLL). Medicine (Baltimore) 49: 505–513, 1970.CrossRefGoogle Scholar
  26. 26.
    Freireich EJ, Thomas LB, Frei E, Fritz RD, Forkner CE: A distinctive type of intracerebral hemorrhage associated with “blastic crisis” in patients with leukemia. Cancer 13: 146–154, 1960.PubMedCrossRefGoogle Scholar
  27. 27.
    Dutcher JP, Schiffer CA, Wiernik PH: Hyperleukocytosis in adult acute nonlymphocytic leukemia: Impact on remission rate and duration, and survival. J Clin Oncol (Sept. ), 1987.Google Scholar
  28. 28.
    Wiernik PH: Management of the acute leukemia patient. Conn Med 39: 681–685, 1975.PubMedGoogle Scholar
  29. 29.
    Wiernik PH, Serpick AA: Prognostic significance of hydroxyurea responsiveness in acute myelocytic leukemia. Int Soc Hematol, XII Congress, abstr p 14, 1968.Google Scholar
  30. 30.
    Preston FE, Sokol RJ, Lilleyman JS, Winfield DA, Blackburn EK: Cellular hyperviscosity as a cause of neurological symptoms in leukemia. Br Med J 1: 476–478, 1978.PubMedCrossRefGoogle Scholar
  31. 31.
    Dearth JC, Fountain KS, Smithson WA, Burgen EO, Gilchrist GS: Extreme leukemic leukocytosis (blast crisis) in childhood. Mayo Clin Proc 53: 107–211, 1978.Google Scholar
  32. 32.
    Bunin NJ, Pui CH: Differing complications of hyperleukocytosis in children with acute lymphoblastic or acute nonlymphoblastic leukemia. J Clin Oncol 3: 1590–1595, 1985.PubMedGoogle Scholar
  33. 33.
    Suri R, Goldman JM, Catovsky D, Johnson SA, Wiltshaw E, Galton DAG: Priapism complicating chronic granulocytic leukemia. Am J Hematol 9: 295–299, 1980.PubMedCrossRefGoogle Scholar
  34. 34.
    Hess CE, Nicholas AB, Hunt WB, Suratt PM: Pseudohypoxemia secondary to leukemia and thrombocytosis. N Engl J Med 301: 361–363, 1979.PubMedCrossRefGoogle Scholar
  35. 35.
    O’Regan S, Carson S, Chesney RW, Drummond RN: Electrolyte and acid-base disturbances in the management of leukemia. Blood 49: 345–353, 1977.PubMedGoogle Scholar
  36. 36.
    Wilson D, Stewart A, Szwed J, Einhorn LH: Cardiac arrest due to hyperkalemia following therapy for acute lymphoblastic leukemia. Cancer 39: 2290–2293, 1977.PubMedCrossRefGoogle Scholar
  37. 37.
    Boles JM, Dutel J, Briere J, Mialon P, Robasckiewicz M, Garre M, Briere J: Acute renal failure caused by extreme hyperphosphatemia after chemotherapy of an acute lymphoblastic leukemia. Cancer 53: 2425–2429, 1984.PubMedCrossRefGoogle Scholar
  38. 38.
    Field M, Block JB, Levin R, Rall DP: Significance of blood lactate elevations among patients with acute leukemia and other neoplastic proliferative disorders. Am J Med 40: 528–545, 1966.CrossRefGoogle Scholar
  39. 39.
    Wainer RA, Wiernik PH, Thompson WL: Metabolic and therapeutic studies of a patient with acute leukemia and severe lactic acidosis of prolonged duration. Am J Med 55: 255–260, 1973.PubMedCrossRefGoogle Scholar
  40. 40.
    Cuttner J, Conjalka MS, Reilly M, Goldberg J, Reisman A, Meyer RJ, Holland JF: Association of monocytic leukemia in patients with extreme leukocytosis. Am J Med 69: 555–558, 1980.PubMedCrossRefGoogle Scholar
  41. 41.
    Wiernik PH, Serpick AA: Clinical significance of serum and urinary muramidase activity in leukemia and other hematologic malignancies. Am J Med 46: 330–343, 1969.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • Janice P. Dutcher
    • 1
    • 2
  1. 1.Department of Medicine, Division of Medical OncologyAlbert Einstein College of MedicineBronxUSA
  2. 2.Department of OncologyMontefiore Medical CenterBronxUSA

Personalised recommendations